Pseudoxanthoma elasticum and angioid streaks

Angioid Streaks in Psuedoxanthoma Elasticum

Pseudoxanthoma elasticum (PXE) is a hereditary disorder that affects primarily the elastic tissues of skin, eyes and blood vessels. Its estimated prevalence is thought to be 1:25,000 100,000. PXE patients also carry an increased risk for cardiovascular and gastrointestinal diseases. Early diagnosis can play a crucial role in preventing early loss of vision and systemic complications in these pa...

Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.

PURPOSE To report the efficacy of intravitreal injection of bevacizumab 1.25 mg (IVB) in the treatment of choroidal neovascularization (CNV) secondary to angioid streaks (AS). METHODS Case review of two patients with CNV secondary to AS treated with three IVB with a 1-year follow up. RESULTS In both patients after 1 year fluorescein angiography and optical coherence tomography showed comple...

Fluorescein study of a family with angioid streaks and pseudoxanthoma elasticum.

A case of pseudoxanthoma elasticum complicated by angioid streaks and hypertension.

Pseudoxanthoma elasticum complicated by angioid streaks and various other vascular problems was described. The patient was a 69-year-old female and was found to be hypertensive with the left ventricular hypertrophy. Skin biopsies from bilateral sides of the neck disclosed a typical lesion indicating pseudoxanthoma elasticum. Subsequently, several complications were sorted out and hypertension h...

Intravitreal Bevacizumab Injection for Choroidal Neovascularisation Secondary to Angioid Streaks in Pseudoxanthoma Elasticum Patients

Submit Manuscript | http://medcraveonline.com Abbreviations: IVB: Intravitreal Bevacizumab; CNV: Choroidal Neovascularization; AS: Angioid Streaks; PXE: Pseudoxanthoma Elasticum; FFA: Fundus Fluorescein Angiography; OCT: Optical Coherence Tomography; RPE: Retinal Pigment Epithelium; PDT: Photo Dynamic Therapy; VEGF: Vascular Endothelial Growth Factor; AMD: Age-related Macular Degeneration; BCVA...